Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Inspections & FDARA: Will New Law Light The Way For Investigators? Maybe, Experts Say

Sep 05 2017

• By Shawn M. Schmitt

Business concept illustration of a businessman being guided by a hand holding a flashlight uncovering arrow sign.

Related Content

'Program Alignment' Falls Into Place: Everything You Need To Know About US FDA's New Inspectional Approach

May 08 2017

'Perfect Storm' Arrives: Clock Ticking For Device Firms To Conform To ISO 13485, MDSAP, EU & ASEAN Regs

May 11 2017

World of Change Coming For Device Manufacturers: Developments In FDA And International Inspections

Aug 25 2017

MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill

Aug 19 2017

New Bill Aims To Bring Consistency, Transparency To US FDA Inspections

Feb 16 2017

FDA's Risk-Based Approach To Facility Inspections Undergoing Refinements

Nov 01 2008

Problems Still Abound For FDA's Accredited Persons Inspection Program

Nov 01 2009

FDA Investigators Play Fast And Loose With Quality System Inspection Technique, Experts Say – But Is It Par For The Course?

Dec 12 2016

Additional Topics

Compliance FDA Quality Enforcement Quality Control Medical Device

More from Compliance

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window